220 related articles for article (PubMed ID: 3754173)
1. The binding of pirenzepine to digitonin-solubilized muscarinic acetylcholine receptors from the rat myocardium.
Birdsall NJ; Hulme EC; Keen M
Br J Pharmacol; 1986 Feb; 87(2):307-16. PubMed ID: 3754173
[TBL] [Abstract][Full Text] [Related]
2. Solubilization and characterization of high and low affinity pirenzepine binding sites from rat cerebral cortex.
Berrie CP; Birdsall NJ; Hulme EC; Keen M; Stockton JM
Br J Pharmacol; 1985 Jul; 85(3):697-703. PubMed ID: 4027484
[TBL] [Abstract][Full Text] [Related]
3. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
el-Fakahany EE; Ramkumar V; Lai WS
J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
Gillard M; Waelbroeck M; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
[TBL] [Abstract][Full Text] [Related]
5. Solubilization with digitonin alters the kinetics of pirenzepine binding to muscarinic receptors from rat forebrain and heart.
Wang JX; Mei L; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1987 Sep; 242(3):981-90. PubMed ID: 3116203
[TBL] [Abstract][Full Text] [Related]
6. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
[TBL] [Abstract][Full Text] [Related]
7. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
Ehlert FJ; Jenden DJ
Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
[TBL] [Abstract][Full Text] [Related]
8. Affinities of muscarinic drugs for [3H]N-methylscopolamine (NMS) and [3H]oxotremorine (OXO) binding to a mixture of M1-M4 muscarinic receptors: use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classes.
Sharif NA; Williams GW; DeSantis LM
Neurochem Res; 1995 Jun; 20(6):669-74. PubMed ID: 7566362
[TBL] [Abstract][Full Text] [Related]
9. Evidence of paired M2 muscarinic receptors.
Potter LT; Ballesteros LA; Bichajian LH; Ferrendelli CA; Fisher A; Hanchett HE; Zhang R
Mol Pharmacol; 1991 Feb; 39(2):211-21. PubMed ID: 1899905
[TBL] [Abstract][Full Text] [Related]
10. Binding and hydrodynamic properties of muscarinic receptor subtypes solubilized in 3-(3-cholamidopropyl)dimethylammonio-2-hydroxy-1-propanesulfonate.
Poyner DR; Birdsall NJ; Curtis C; Eveleigh P; Hulme EC; Pedder EK; Wheatley M
Mol Pharmacol; 1989 Sep; 36(3):420-9. PubMed ID: 2506431
[TBL] [Abstract][Full Text] [Related]
11. Binding characteristics and functional G protein coupling of muscarinic acetylcholine receptors in rat duodenum smooth muscle membranes.
Liebmann C; Nawrath S; Schnittler M; Schubert H; Jakobs KH
Naunyn Schmiedebergs Arch Pharmacol; 1992 Jan; 345(1):7-15. PubMed ID: 1538792
[TBL] [Abstract][Full Text] [Related]
12. In vitro effects of gallamine on dissociation kinetics of (3H)N-methylscopolamine and (3H)pirenzepine from rat brain muscarinic receptors.
Gillard M; Waelbroeck M; Christophe J
J Recept Res; 1986; 6(1):47-61. PubMed ID: 3754901
[TBL] [Abstract][Full Text] [Related]
13. [3H]oxotremorine-M binding to membranes prepared from rat brain and heart: evidence for subtypes of muscarinic receptors.
Bevan P
Eur J Pharmacol; 1984 May; 101(1-2):101-10. PubMed ID: 6547676
[TBL] [Abstract][Full Text] [Related]
14. Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies.
Cortés R; Probst A; Tobler HJ; Palacios JM
Brain Res; 1986 Jan; 362(2):239-53. PubMed ID: 3753655
[TBL] [Abstract][Full Text] [Related]
15. Solubilization and characterization of atrial muscarinic acetylcholine receptors in sucrose monolaurate.
Rinken A; Haga T
Arch Biochem Biophys; 1993 Feb; 301(1):158-64. PubMed ID: 8442658
[TBL] [Abstract][Full Text] [Related]
16. Enrichment, solubilization, and partial characterization of digitonin-solubilized muscarinic receptors derived from canine ventricular myocardium.
Manalan AS; Werth DK; Jones LR; Watanabe AM
Circ Res; 1983 Jun; 52(6):664-76. PubMed ID: 6305530
[TBL] [Abstract][Full Text] [Related]
17. Short-term desensitization of muscarinic cholinergic receptors in mouse neuroblastoma cells: selective loss of agonist low-affinity and pirenzepine high-affinity binding sites.
Cioffi CL; el-Fakahany EE
J Pharmacol Exp Ther; 1986 Sep; 238(3):916-23. PubMed ID: 3018226
[TBL] [Abstract][Full Text] [Related]
18. Binding profile of a novel cardioselective muscarine receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the rat.
Hammer R; Giraldo E; Schiavi GB; Monferini E; Ladinsky H
Life Sci; 1986 May; 38(18):1653-62. PubMed ID: 3754610
[TBL] [Abstract][Full Text] [Related]
19. Cooperativity manifest in the binding properties of purified cardiac muscarinic receptors.
Wreggett KA; Wells JW
J Biol Chem; 1995 Sep; 270(38):22488-99. PubMed ID: 7673239
[TBL] [Abstract][Full Text] [Related]
20. Kinetic studies of [3H]-N-methylscopolamine binding to muscarinic receptors in the rat central nervous system: evidence for the existence of three classes of binding sites.
Waelbroeck M; Gillard M; Robberecht P; Christophe J
Mol Pharmacol; 1986 Oct; 30(4):305-14. PubMed ID: 3762520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
